
Sign up to save your podcasts
Or
Join your host, Henry Norton, and David Caumartin, the CEO of RebrAIn, as they discuss the impact that machine learning and artificial intelligence are having on the clinical outcomes of neurosurgery procedures.
During the episode, David shares his medtech story, from how he entered the field to what drew him to RebrAIn several years ago.
He also talks about his experience of working with neurosurgeons and how that differs from the other fields he specialised in, such as mammography.
David goes on to discuss the benefits of AI in the surgical space, suggesting that it can improve surgeons’ accuracy, patient outcomes and medical research.
He also touched on RebrAIn’s clinical trials and the findings that are emerging from them.
Key Topics:
David’s transition from GE to startup
RebrAIn’s unique AI technology
The challenges and opportunities within the US market
The impact of AI on healthcare
Related Insights:
AI is making healthcare smarter, faster, and more efficient
Collaboration is the key to progress in the healthcare field
RebrAIn’s technology can create accurate targets from 100 cases rather than 20,000
Core Challenges:
The brain is one of the most delicate parts of human anatomy. In order to successfully operate on it, surgeons have to be as precise as possible. Factors like hand tremors, indecision or human error can have a huge impact on patient outcomes.
With an AI assistant, surgeons can assess the best course of action more quickly and accurately. RebrAIn’s AI tool serves as another neurosurgeon in the room.
Tune in now to discover the future of neurosurgery.
The Crux of MedTech podcast is brought to you by Cruxx, a specialist surgical robotics recruitment agency.
To learn more about Cruxx, click here.
A big thank you to our sponsors on this season of the podcast;
TTP plc With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, TTP plc can accelerate your development with the latest technologies. Learn more at TTP.com
&
KUKA is a global leader in robotics with over 25 years of experience partnering with medtech companies on their journey to market. Their reputation is built on robust technology, reliability and long term collaboration and being more than just a supplier.
KUKA provides trusted support throughout the product life cycle, from development to integration and beyond.
Find out more at kuka.com/healthcare
5
22 ratings
Join your host, Henry Norton, and David Caumartin, the CEO of RebrAIn, as they discuss the impact that machine learning and artificial intelligence are having on the clinical outcomes of neurosurgery procedures.
During the episode, David shares his medtech story, from how he entered the field to what drew him to RebrAIn several years ago.
He also talks about his experience of working with neurosurgeons and how that differs from the other fields he specialised in, such as mammography.
David goes on to discuss the benefits of AI in the surgical space, suggesting that it can improve surgeons’ accuracy, patient outcomes and medical research.
He also touched on RebrAIn’s clinical trials and the findings that are emerging from them.
Key Topics:
David’s transition from GE to startup
RebrAIn’s unique AI technology
The challenges and opportunities within the US market
The impact of AI on healthcare
Related Insights:
AI is making healthcare smarter, faster, and more efficient
Collaboration is the key to progress in the healthcare field
RebrAIn’s technology can create accurate targets from 100 cases rather than 20,000
Core Challenges:
The brain is one of the most delicate parts of human anatomy. In order to successfully operate on it, surgeons have to be as precise as possible. Factors like hand tremors, indecision or human error can have a huge impact on patient outcomes.
With an AI assistant, surgeons can assess the best course of action more quickly and accurately. RebrAIn’s AI tool serves as another neurosurgeon in the room.
Tune in now to discover the future of neurosurgery.
The Crux of MedTech podcast is brought to you by Cruxx, a specialist surgical robotics recruitment agency.
To learn more about Cruxx, click here.
A big thank you to our sponsors on this season of the podcast;
TTP plc With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, TTP plc can accelerate your development with the latest technologies. Learn more at TTP.com
&
KUKA is a global leader in robotics with over 25 years of experience partnering with medtech companies on their journey to market. Their reputation is built on robust technology, reliability and long term collaboration and being more than just a supplier.
KUKA provides trusted support throughout the product life cycle, from development to integration and beyond.
Find out more at kuka.com/healthcare
47 Listeners
3,140 Listeners
111,083 Listeners
55,867 Listeners
13,694 Listeners
329 Listeners
6,892 Listeners
10,085 Listeners
5,920 Listeners
8,759 Listeners
5,410 Listeners
15,313 Listeners